FIELD: medicine, neurology.
SUBSTANCE: erythropietin should be injected peripherally at the dosage of 5000 - 100000 IU. Moreover, as erythropoietin one should inject either human native or recombinant or animal erythropoietin or their derivative. The method enables to decrease complications due to excluding traumatic way of injection.
EFFECT: higher efficiency of therapy.
21 cl, 2 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATING ISCHEMIA AND CEREBRAL LESION WITH A NEUROPROTECTOR PREPARATION | 1996 |
|
RU2194527C2 |
ERYTHROPOIETIN APPLICATION FOR POSTINSULT REHABILITATION | 2004 |
|
RU2341284C2 |
CDP-CHOLINE - PROPHYLACTIC AGENT FOR TREATMENT OF CEREBRAL ISCHEMIA AND METHOD FOR TREATMENT WITH ITS USING | 2001 |
|
RU2255741C2 |
METHOD OF TREATING CEREBRAL ISCHEMIA IN EXPERIMENT | 2012 |
|
RU2495688C1 |
METHODS, PHARMACEUTICAL COMPOSITIONS AND PRODUCTS FOR THERAPEUTIC CELL INTRODUCTION INTO ANIMAL'S CENTRAL NERVOUS SYSTEM | 2008 |
|
RU2468818C2 |
METHOD OF TREATING SPINAL ISCHEMIA IN EXPERIMENT | 2012 |
|
RU2496513C1 |
TREATMENT OF NEUROLOGICAL DYSFUNCTION BY USING FRUCTOPYRANOSE AND ERYTHROPOIETIN SULFAMATES | 2002 |
|
RU2317086C2 |
METHOD FOR TREATMENT OF CEREBRAL ISCHEMIA | 2005 |
|
RU2281765C1 |
VERSIONS OF ERYTHROPOETINE | 2006 |
|
RU2430162C2 |
METHOD FOR PREVENTING AND TREATING ISCHEMIA ATTACKS AND REPERFUSION INJURIES ARISING DUE TO THE ATTACK | 1994 |
|
RU2153353C2 |
Authors
Dates
2004-12-27—Published
1999-12-13—Filed